Article · 18 Dec 2025
Conference abstract
Primary antimicrobial susceptibility changes in children with Helicobacter pylori infection over 13 years in northern Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The eradication therapy of Helicobacter pylori infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. The culture from biopsies maybe the most used method among the antimicrobial susceptibility testing, but despite of its high costs it has a variable success rate of development. Although the main international guidelines still recommend the triple therapy as first-line therapy in eradication of H. pylori infection, this therapeutic regimen is decreasing of efficacy all over the world. We compared the antimicrobial susceptibilities in children with H. pylori infection over 13 years and we confirmed that the clarithromycin resistance is strongly increasing, as noted by many authors in the world. Therefore the clarithromycin should not be used as empiric treatment of H. pylori infection, but its use should be limited only to those patients with known antimicrobial susceptibility. If we don't know the antibiotic susceptibility of patients, we should recommend an eradication therapy based on the local distribution of antibiotic resistance rates thus trying to limit the therapeutic failures. Many studies confirmed that sequential therapy achieves a good effectiveness even in patients with clarithromycin and metronidazole resistance, therefore if we don't know neither the antimicrobial susceptibility nor the local distribution of antibiotic resistance, in our opinion, sequential therapy could provide the best eradication rate as empiric treatment.
Keywords
Subjects
MicrobiologyInfectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Microbiology: Open Access.
Article · 18 Dec 2025
Culture-Based and Molecular Assessment of Microbial Diversity
Article · 18 Dec 2025
Antimicrobial Resistance Detection and Microbial Identification
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Microbiology: Open Access
- SubjectMicrobiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Marco Manfredi”
